Scarica l'app Stockscreener
2.12
6.19%
-0.14
Pre-mercato:
2.18
0.06
+2.83%
Precedente Chiudi:
$2.26
Aprire:
$2.24
Volume 24 ore:
4.77M
Relative Volume:
1.41
Capitalizzazione di mercato:
$719.23M
Reddito:
-
Utile/perdita netta:
$-75.80M
Rapporto P/E:
-6.0571
EPS:
-0.35
Flusso di cassa netto:
$-68.07M
1 W Prestazione:
-7.83%
1M Prestazione:
-2.75%
6M Prestazione:
-26.90%
1 anno Prestazione:
-29.10%
Intervallo 1D:
$2.11
$2.27
Intervallo di 1 settimana:
$2.11
$2.415
Portata 52W:
$1.54
$3.97
Nuvation Bio Inc Stock (NUVB) Company Profile
Nome
Nuvation Bio Inc
Settore
Industria
Telefono
(415) 754-3517
Indirizzo
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Confronta NUVB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
2.12 | 782.60M | 0 | -75.80M | -68.07M | -0.35 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-23 | Iniziato | Citizens JMP | Mkt Outperform |
| 2024-03-27 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-03-26 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-01-06 | Downgrade | Jefferies | Buy → Hold |
| 2022-08-02 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-05-04 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-04-06 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-03-08 | Iniziato | BMO Capital Markets | Outperform |
| 2021-03-08 | Iniziato | BTIG Research | Buy |
| 2021-03-08 | Iniziato | Cowen | Outperform |
| 2021-03-08 | Iniziato | Jefferies | Buy |
| 2021-03-08 | Iniziato | Wedbush | Outperform |
Mostra tutto
Nuvation Bio Inc Borsa (NUVB) Ultime notizie
JMP maintains $6 target on Nuvation Bio stock ahead of PDUFA - Investing.com India
Nuvation Bio Inc. (NYSE:NUVB) Shares Sold by Nuveen Asset Management LLC - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $276,000 Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Deutsche Bank AG Increases Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Citizens JMP highlights key ASCO presentations - Investing.com
Citizens JMP highlights key ASCO presentations By Investing.com - Investing.com UK
D. E. Shaw & Co. Inc. Sells 63,827 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc. (NYSE:NUVB) Shares Acquired by Millennium Management LLC - Defense World
Nuvation Bio Inc. Ratifies the Appointment of KPMG LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025 - marketscreener.com
Nuvation Bio Holds Successful Annual Meeting 2025 - TipRanks
Nuvation Bio stockholders approve board members and executive pay - Investing.com
Nuvation Bio’s SWOT analysis: taletrectinib approval could transform stock outlook - Investing.com Australia
Nuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual Meeting - New Castle News
Northern Trust Corp Acquires 563,627 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Brokerages Set Nuvation Bio Inc. (NYSE:NUVB) Target Price at $7.83 - Defense World
Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way? - simplywall.st
Wedbush Reiterates Outperform Rating for Nuvation Bio (NYSE:NUVB) - Defense World
Nuvation Bio (NUVB) Maintains Outperform Rating by Wedbush | NUV - GuruFocus
Nuvation Bio (NUVB) Maintains Outperform Rating by Wedbush | NUVB Stock News - GuruFocus
Dimensional Fund Advisors LP Cuts Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Entrectinib at ISPOR 2025 - BioSpace
Breakthrough Comparison: How Nuvation's Cancer Drug Stacks Up Against Entrectinib in Crucial Lung Cancer Study - Stock Titan
Nuvation Bio Inc. (NYSE:NUVB) Q1 2025 Earnings Call Transcript - Insider Monkey
Nuvation Bio Inc. (NYSE:NUVB) Shares Bought by Price T Rowe Associates Inc. MD - Defense World
Nuvation Bio to Participate in Upcoming May 2025 Investor Conferences - BioSpace
Nuvation Bio’s Positive Outlook: Taletrectinib Approval and Financial Strength - TipRanks
Nuvation Bio to Participate in Upcoming Investor Conferences - Yahoo
Wedbush Issues Positive Outlook for Nuvation Bio Earnings - Defense World
FY2029 Earnings Forecast for Nuvation Bio Issued By Wedbush - Defense World
Nuvation Bio Inc (NUVB) Q1 2025 Earnings Call Highlights: Promising Developments and Strategic Moves - Investing.com Canada
Nuvation Bio Inc. (NUVB): Among Billionaire David Abrams’ Stock Picks with Huge Upside Potential - Insider Monkey
Nuvation Bio Inc. (NUVB) Reports Q1 Loss, Tops Revenue Estimates - MSN
Nuvation Bio: Undervalued Growth Potential with Key Developments on the Horizon - TipRanks
MetLife Investment Management LLC Buys 12,596 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Earnings call transcript: Nuvation Bio Q1 2025 sees strategic focus amid EPS miss - Investing.com
Nuvation Bio Reports First Quarter 2025 Financial Results and Provides Business Update - BioSpace
Nuvation Bio Reports Q1 2025 Results and Business Updates - TipRanks
Nuvation Bio (NUVB) Eyes U.S. Approval for Key Lung Cancer Treat - GuruFocus
Nuvation Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Stock Performance Spotlight: Nuvation Bio Inc (NUVB) Ends the Day at 2.09, Down by -12.18 - DWinneX
Nuvation Bio: A Real Shot To Move The Needle In Lung Cancer Subtypes (NYSE:NUVB) - Seeking Alpha
Wells Fargo & Company MN Increases Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio (NYSE:NUVB) Shares Down 8.2% After Insider Selling - Defense World
Nuvation Bio Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
JPMorgan Chase & Co. Sells 322,798 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc (NUVB) Stock: A Year of Stock Market Dynamics - investchronicle.com
Invesco Ltd. Buys 7,344 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
LPL Financial LLC Grows Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio to Present at The Citizens Life Sciences Conference - BioSpace
Nuvation Bio Inc [NUVB] Records 50-Day SMA of $1.98 - knoxdaily.com
Nuvation Bio Inc Azioni (NUVB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.89%
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):